- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
Learn about the different avenues for sharing, submitting and amplifying CTSA Program-related communications by both NCATS and CLIC
Keep up-to-date on what is happening in the consortium
Insights to Inspire 2022: In Our Own Words is a collection of Program Summaries from across the consortium for the Careers in Clinical & Translational Research (CCTR) metric. From 36 unique hubs come insights into how hubs are working to improve the experiences of their KL2 scholars and TL1 trainees. Starting in December 2021 and extending through April 2022, In Our Own Words will feature one of
Researchers are working to better prepare for the next pandemic. One of those researchers is Kevin Messacar, MD, PhD, an infectious disease expert and physician at Children’s Hospital Colorado and associate professor at the University of Colorado Anschutz Medical Campus. Messacar is leading an innovative, nationwide pilot study focusing on enterovirus D68, a virus that is linked to a rare polio
Ten years ago, people with cystic fibrosis (CF) celebrated when the FDA approved ivacaftor, the first drug designed to target the defective protein that causes the disease. CF is an inherited disorder that inflicts severe damage to the lungs, digestive system and other organs in the body. Since then, several additional drugs that use a similar mechanism have been approved by the FDA for CF. These
The massive volume of messages we all have received about COVID-19 led the World Health Organization to coin the term “infodemic”: too much information, including false or misleading messages, in digital and physical environments during a disease outbreak. Though academics will be studying the toll of this misinformation for many years to come, we know it has been massive. One way the National
The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal
A youth shelter and University of Minnesota researchers teamed up to address the unmet needs of pregnant or parenting teens who are also facing homelessness. This vulnerable group often slips through the cracks of social services, finding themselves both ineligible for shelter and with few healthcare resources to meet their unique needs. Janna Gewirtz O'Brien, MD, MPH, an Assistant Professor at
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths. Some COVID-19 patients experience an immune
SDoH are the non-clinical covariates of how people live, grow, learn and age and relates to how people manage stressors or prevent worsening health outcomes. Progressively, data about patient-level SDoH are collected using clinical screening tools for social needs and social risk factors. CD2H has led multiple SDoH synergistic initiatives relating to overall improvement of SDoH encoding and
The ICTS has awarded four separate awards to investigators in the ICTS’ first-ever virtual poster display and contest. As part of the 4th annual ICTS Symposium, 47 separate posters were submitted and reviewed by 22 ICTS faculty from Washington University in St. Louis, University of Missouri – Columbia, and Saint Louis University. Posters showcased ICTS-supported research and were categorized by
The Washington University Institute of Clinical and Translational Sciences (ICTS) hosted their 4th annual Symposium and Poster Display on Friday, May 13, 2022. The theme “Making an Impact, Shaping the Future” focused on strategies to address equity and diversity challenges experienced by institutions across the national Clinical and Translational Science Awards (CTSA) network. The hybrid event
The Columbia University CTSA is proud to present this year’s Honorary Leahey Lecture Series, as part of the Medicine Grand Rounds David Kessler, MD Chief Science Officer for COVID Response for the administration of President Joe Biden A moderated discussion between Dr. Kessler and Dr. Magda Sobieszczyk: Dr. Kessler has been spearheading the vaccine and therapeutics initiatives for the White House
When scientific advances burst into the news, such as a new medication to treat COVID-19 or a new concept like CRISPR for gene editing, people get a glimpse of how a scientific idea becomes a treatment or a tool. But what's the full story? Where did that idea come from? What happens in the research lab before clinical trials begin? How is scientific discovery transformed into a potential therapy
Washington University School of Medicine in St. Louis has received a $61 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) to support the infrastructure for developing and carrying out biomedical research studies. The funding supports Washington University’s Institute of Clinical and Translational Sciences (ICTS), which was
Former participants in iTHRIV's "Inspiring Diverse Researchers in Virginia" (iDRIV), Angelina June, MD and Ifeyinwa Obiorah, MD have been inducted into UVA's Academy for Excellence in Education. Founded in 2020, the Academy for Excellence in Education aims to build an inclusive learning community of educators across the biomedical sciences and UVA Health to foster and honor educational excellence
The University of Rochester Clinical and Translational Science Institute (UR CTSI) has awarded four new KL2 Career Development Awards to early-career clinical and translational scientists across the University of Rochester Medical Center. Awardees will soon begin two years of mentored research with KL2 support that is designed to help them obtain further K- or R- awards to advance their careers
A new video sponsored by the University of Arkansas for Medical Sciences (UAMS) Translational Research Institute (TRI) is being used to help raise awareness among researchers about the inclusion of older adults in research. The five-minute video also has tips for helping researchers recruit more adults over age 65. The video was produced in collaboration with the UAMS Northwest Regional Campus
As COVID-19 vaccines are approved for pediatric populations, a cross-collaborative effort between the USC School of Cinematic Arts, the Annenberg School for Communication and Journalism, and the Keck School of Medicine seeks to highlight the importance of getting vaccinated to protect yourself and your family. This successful collaboration resulted in the creation, production and dissemination of
Assefa, a recent graduate of UVA, participated in the UVA-Historically Black Colleges and Universities Summer Research Bridge to Data Science program (Bridge) as a research fellow. This program is co-sponsored by integrated Translational Health Research Institute of Virginia (iTHRIV), the UVA School of Data Science (UVA SDS), Oracle, and Deloitte. According to the UVA SDS, the UVA-HBCU Summer
Since 2007, the Institute of Translational Health Sciences (ITHS) has partnered with the University of Washington (UW), Fred Hutchinson Cancer Research Center, and Seattle Children’s on a Clinical and Translational Science Award (CTSA). This hub serves a large five-state region—Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI)—encompassing rural and urban communities with unique health